share_log

Walgreens Boots Alliance Declares Quarterly Dividend

Walgreens Boots Alliance Declares Quarterly Dividend

沃尔格林靴子联盟宣布季度分红
沃尔格林-联合博姿 ·  04/25 00:00

DEERFIELD, Ill.--Apr. 25, 2024-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on June 12, 2024, to stockholders of record as of May 21, 2024.

伊利诺伊州迪尔菲尔德--2024年4月25日--沃尔格林靴子联盟有限公司(纳斯达克股票代码:WBA)今天宣布,其董事会已宣布季度股息为每股25美分,与上一季度持平。股息将于2024年6月12日支付给截至2024年5月21日的登记股东。

Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 366 straight quarters (91 years).

Walgreens Boots Alliance及其前身沃尔格林公司已连续366个季度(91年)派发股息。

About Walgreens Boots Alliance

关于沃尔格林靴子联盟

Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.

Walgreens Boots Alliance(纳斯达克股票代码:WBA)是一家综合医疗保健、药房和零售业的领导者,每天为数百万客户和患者提供服务,拥有170年关爱社区的传统。

A trusted, global innovator in retail pharmacy with approximately 12,500 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The Company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.

作为零售药房领域值得信赖的全球创新者,WBA在美国、欧洲和拉丁美洲拥有约12,500个分支机构,在医疗保健生态系统中发挥着至关重要的作用。该公司正在重新构想当地的医疗保健和全民福祉,这是其目标之一——通过更好的健康创造更快乐的生活。通过配发药物、改善获得广泛医疗服务的机会、提供高质量的健康和美容产品以及通过其数字平台随时随地提供便利,WBA正在塑造医疗保健的未来。

WBA employs more than 315,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.

WBA拥有超过31.5万名员工,通过其消费品牌组合在八个国家开展业务:Walgreens、Boots、Duane Reade、No7美容公司和墨西哥的贝纳维德斯。此外,WBA在包括中国和美国在内的多个国家拥有以医疗保健为重点的投资组合。

The Company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: the Company is an index component of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Best Corporate Citizens 2022.

公司为其对健康社区、健康地球、包容性工作场所和可持续市场的贡献感到自豪。WBA因其对可持续发展的承诺而获得认可:该公司是道琼斯可持续发展指数(DJSI)的指数组成部分,并入选2022年100位最佳企业公民。

More Company information is available at www.walgreensbootsalliance.com.

更多公司信息可在以下网址获得 www.walgreensbootsalliance.com

Cautionary Note Regarding Forward-Looking Statements: All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding capital allocation, the anticipated effects on our long-term balance sheet and cash position as a result of reducing our dividend, our expectations to right-size costs, increase cash flow and invest in sustainable growth initiatives in the pharmacy and healthcare businesses, and our ability to balance capital allocation priorities. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including the financial performance of our consolidated subsidiaries in the U.S. Healthcare segment, as well as those described in Item 1A (Risk Factors) of our Form 10-K for the fiscal year ended August 31, 2023 and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. These forward-looking statements speak only as of the date they are made. We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

关于前瞻性陈述的警示说明:本新闻稿中所有非历史陈述均为根据1995年《私人证券诉讼改革法》的安全港条款作出的前瞻性陈述,包括但不限于有关资本配置、股息减少对长期资产负债表和现金状况的预期影响、我们对调整成本、增加现金流和投资药房和医疗保健业务可持续增长计划的期望,以及我们平衡资本配置优先事项的能力。这些前瞻性陈述不能保证未来的业绩,涉及风险、假设和不确定性,包括我们在美国医疗保健领域的合并子公司的财务业绩,以及截至2023年8月31日财年的10-K表第1A项(风险因素)以及我们向美国证券交易委员会提交或提供的其他文件中描述的业绩。如果其中一项或多项风险或不确定性成为现实,或者基本假设被证明不正确,则实际结果可能与此类前瞻性陈述所示或预期的结果存在重大差异。这些前瞻性陈述仅代表其发表之日。在本新闻稿发布之日之后,无论是由于新信息、未来事件、假设变化还是其他原因,我们均不承担也不承担任何义务或义务公开更新任何前瞻性陈述。

WBA Media Relations

WBA 媒体关系

USA / Jim Cohn, media@wba.com
International, +44 (0)20 7980 8585

美国/吉姆·科恩, media@wba.com
国际,+44 (0) 20 7980 8585

WBA Investor Relations

WBA 投资者关系

Chris Deyo, +1 847 315 2922

Chris Deyo,+1 847 315 2922

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发